Every Form 4 that Insulet Corporation (PODD) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow PODD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PODD filings page.
INSULET CORP (PODD) director and President and CEO Ashley McEvoy reported an open-market purchase of 1,100 shares of common stock on 2026-08-21 at a weighted average price of $147.47 per share, with individual trade prices ranging from $147.42 to $147.62. After this transaction, McEvoy directly holds 23,731 shares of Insulet common stock, which include 80 shares acquired through the Insulet Corporation Employee Stock Purchase Plan since the prior Form 4 filing, and also reports 4 shares held indirectly by a trust.
Insulet Corp executive Lisa Blair Davis, SVP and Chief HR Officer, reported a tax-withholding disposition of 244 shares of common stock on 2026-08-01 at $165.35 per share to cover RSU-related tax obligations. After this withholding, she directly holds 4,453 shares, including 80 shares acquired through the Employee Stock Purchase Plan.
Insulet Corp director Robert Luther Huffines reported an amended grant of 151 deferred common stock units received in lieu of cash fees under the company’s Deferred Compensation Plan for Non-Employee Directors. These Deferred Units convert into common stock on a one-for-one basis upon distribution.
The amendment corrects an administrative error in the original Form 4, revising the award to 151 units at a price of $152.25 per unit, instead of 144 units at $159.79. Following this adjustment, Huffines holds 2,449 shares directly.
INSULET CORP director Jonathan Jay Mazelsky received an initial equity award in the form of restricted stock units, which convert into common shares on a one-for-one basis. The award covers 1,355 shares of common stock at a stated price of $0.00 per share, reflecting a compensation grant rather than an open-market purchase.
After this grant, Mazelsky directly holds 1,355 shares of Insulet common stock according to the filing. The transaction is categorized as a grant, award, or other acquisition of non-derivative common stock, tied to his role on the company’s board.
INSULET CORP director Robert Luther Huffines received a grant of 144 deferred common stock units, valued at $159.79 per unit. These units were awarded as non-cash compensation under the Company’s Deferred Compensation Plan for Non-Employee Directors and will convert into common shares on a one-for-one basis upon distribution.
After this grant, Huffines is reported as directly holding 2,442 shares of common stock. Distribution of the underlying shares will occur in either a lump sum or substantially equal annual installments, at the director’s election under the plan.
INSULET CORP director Timothy C. Stonesifer bought shares of the company in the open market. On June 3, he purchased 2,790 shares of Insulet common stock at $143.51 per share. After this transaction, his direct holdings increased to 9,041 common shares.
INSULET CORP director Luciana Borio sold 418 shares of Common Stock in an open-market transaction on June 3, 2026, at an average price of $143.27 per share. After this sale, she directly owns 4,329 company shares, indicating she retains a meaningful ongoing equity stake.
INSULET CORP director Elizabeth H. Weatherman reported an open-market purchase of Common Stock. She bought 3,450 shares at a weighted average price of $144.20 per share, increasing her direct holdings to 10,352 shares after the transaction.
The shares were acquired in multiple trades: 1,607 shares at prices ranging from $143.21 to $144.13 with a weighted average of $143.65, and 1,843 shares at prices ranging from $144.22 to $145 with a weighted average of $144.69.
WEATHERMAN ELIZABETH H reported acquisition or exercise transactions in this Form 4 filing.
Insulet Corp director Elizabeth H. Weatherman received an annual equity award of 1,660 restricted stock units (RSUs). The award is priced at $0.00 per share, indicating it is a stock-based compensation grant rather than a market purchase. These RSUs will settle into common shares on a one-for-one basis and vest in full on April 30, 2027. After this grant, she holds a total of 6,902 shares of Insulet common stock directly.
STONESIFER TIMOTHY C. reported acquisition or exercise transactions in this Form 4 filing.
INSULET CORP director Timothy C. Stonesifer received an annual equity award of 1,660 restricted stock units. The RSUs will settle one-for-one in common stock and vest in full on April 30, 2027. Following this grant, he directly holds 6,251 shares, reflecting routine, compensation-related equity rather than an open-market purchase.
INSULET CORP director Timothy J. Scannell received an annual equity award in the form of restricted stock units. The grant covers 1,660 shares of common stock, awarded at no cash cost and recorded as an acquisition of common stock.
The RSUs will be settled in shares of common stock on a one-for-one basis and vest in full on April 30, 2027. After this award, Scannell directly holds 33,024 shares of Insulet common stock, showing this is a routine, compensation-related equity grant rather than an open-market purchase or sale.
MINOGUE MICHAEL R reported acquisition or exercise transactions in this Form 4 filing.
INSULET CORP director Michael R. Minogue reported an equity grant and updated share holdings. He received an annual equity award of 1,660 restricted stock units (RSUs), which will be settled one-for-one in common shares and vest in full on April 30, 2027. Following the grant, he holds 2,438 common shares directly and 17,483 common shares indirectly through a trust.
Huffines Robert Luther reported acquisition or exercise transactions in this Form 4 filing.
Insulet Corp director Robert Luther Huffines received an annual equity award of 1,660 shares of common stock in the form of restricted stock units at no cash cost. These RSUs vest in full on April 30, 2027 and will be settled one-for-one in shares after his board service ends, according to his deferral election. Following this grant, he beneficially owns 2,298 common shares directly.
Hopfield Jessica reported acquisition or exercise transactions in this Form 4 filing.
Insulet Corp director Jessica Hopfield received an equity award of 1,660 restricted stock units (RSUs) of common stock. The award was granted at no cash cost to her as part of annual equity compensation. These RSUs will vest in full on April 30, 2027 and settle one-for-one in Insulet common shares. After this grant, she directly holds 29,355 shares of Insulet common stock, highlighting that the transaction reflects compensation rather than an open-market purchase or sale.
Frederick Wayne A.I. reported acquisition or exercise transactions in this Form 4 filing.
INSULET CORP director Frederick Wayne A.I. received an equity grant of 1,660 shares of common stock on a grant/award basis, with no cash paid per share. These are restricted stock units that vest in full on April 30, 2027. After the award, he holds 3,818 shares directly. Settlement of the vested RSUs is deferred under Insulet’s non-employee director deferred compensation plan until after his board service ends.
BORIO LUCIANA reported acquisition or exercise transactions in this Form 4 filing.
INSULET CORP director Luciana Borio received an equity grant of 1,660 shares of common stock in the form of restricted stock units. The RSUs are an annual equity award that will be settled on a one-for-one basis in common stock. They vest in full on April 30, 2027, aligning her compensation with long-term shareholder interests. Following this award, she holds a total of 4,747 shares of Insulet common stock directly.
Insulet Corp President and CEO Ashley McEvoy reported a routine tax-related share disposition and updated holdings. A total of 1,411 shares of common stock were withheld on May 13, 2026 at $148.84 per share to cover tax obligations tied to vesting restricted stock units, according to the footnote. After this withholding, McEvoy directly owns 22,551 common shares and indirectly holds 4 additional shares through a trust.
Insulet Corp EVP and CCO Michael Panos received new equity awards. He was granted an employee stock option covering 7,255 shares of common stock at an exercise price of $207.04 per share, expiring on April 1, 2036. These non-qualified stock options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date.
He also received 2,777 restricted stock units that vest in substantially equal installments on each of the first, second and third anniversaries of the grant date and are settled one-for-one in common shares. Following these grants, he directly holds 2,782 shares of common stock and 7,255 stock options.
INSULET CORP director Robert Luther Huffines received an award of 111 deferred common stock units of Insulet common stock on March 31, 2026, valued at $209.84 per unit. This grant was made in lieu of cash board compensation under the company’s Deferred Compensation Plan for Non-Employee Directors and increased his reported holdings to 638 shares or units.
The deferred common stock units will convert into the same number of Insulet common shares upon distribution, with any fractional share value paid in cash. Distribution occurs at the director’s election, either in a lump sum or in substantially equal annual installments, consistent with the plan’s terms.
INSULET CORP senior vice president Prem Singh reported routine share dispositions related to tax withholding on vested equity. On February 27, 2026, a total of 269 shares of common stock were withheld at $246.61 per share to cover tax obligations from restricted stock units vesting. These transactions are coded as tax-withholding dispositions, not open-market sales, and Singh continued to hold several thousand shares directly afterward.
INSULET CORP senior vice president Laetitia Cousin reported small share disposals tied to tax withholding, not open-market selling. On the vesting of restricted stock units, 200 and 53 shares of common stock were withheld at a price of $246.61 per share to cover associated tax obligations. After these transactions, she directly held 5,674 shares of Insulet common stock.
INSULET CORP executive reports tax-related share withholdings
Insulet Corp Group VP, CAO and Controller Lauren Budden reported two Form 4 transactions on common stock dated February 27, 2026. The transactions were coded "F," meaning shares were withheld to satisfy tax obligations upon vesting of restricted stock units, rather than open-market sales.
Budden had 119 shares and 99 shares withheld at a reference price of $246.61 per share to cover associated taxes. Following these non-market dispositions, she directly holds 8,526 shares of Insulet common stock.
Insulet Corp SVP and General Counsel John W. Kapples reported routine share withholding to cover taxes on vested stock awards. On February 27, 2026, 411 and 194 shares of Insulet common stock were disposed of at $246.61 per share through tax-withholding transactions.
According to the filing, these dispositions were for tax obligations tied to restricted stock units vesting, rather than open-market sales. After these transactions, Kapples directly held 27,514 shares of Insulet common stock.
INSULET CORP EVP and COO Eric Benjamin reported tax-related share dispositions, not open-market sales. On February 27, 2026, he surrendered 644 and 268 shares of common stock at $246.61 per share to cover tax obligations upon vesting of restricted stock units, and continued to hold directly owned shares afterward.
INSULET CORP senior executive Prem Singh reported routine equity compensation activity. He received a grant of 2,140 shares of common stock as a restricted stock unit award that vests over three years and 5,570 non-qualified stock options that vest over four years. On a separate date, 138 shares of common stock were withheld to satisfy tax obligations upon RSU vesting, a non-market transaction, leaving him with 7,160 directly owned shares.
INSULET CORP senior vice president Laetitia Cousin reported equity compensation and related tax withholding transactions. She received an annual grant of 1,044 shares of common stock as restricted stock units that vest in three substantially equal installments on the first, second and third anniversaries of the grant date.
She also received an annual non-qualified stock option award for 2,718 shares that becomes exercisable in four substantially equal installments on each of the first four anniversaries of the grant date. In a separate transaction, 111 shares of common stock were withheld at a price of $248.12 per share to cover tax obligations upon RSU vesting.
Insulet Corp Group VP, CAO and Controller Lauren Budden reported routine equity compensation transactions. She received a grant of 611 shares of common stock and an option for 1,591 shares, both at a grant price of $0.00 per share, reflecting stock-based awards rather than open‑market activity.
To cover taxes on vested restricted stock units, 55 shares of common stock were withheld at a price of $248.12 per share, characterized as a tax-withholding disposition. Following these transactions, she directly owned 8,744 common shares and held an option for 1,591 shares, with vesting and exercisability occurring in installments over several years.
INSULET CORP senior vice president and general counsel John W. Kapples reported routine equity compensation and related tax withholding transactions. On February 24, he received an annual grant of 1,885 shares of common stock as restricted stock units that vest in three equal installments and settle one-for-one in common shares. He also received an annual non-qualified stock option award for 4,907 shares, which becomes exercisable in four equal installments over four years. On February 25, 263 shares of common stock were withheld at a price of $248.12 per share to cover tax obligations from vesting RSUs, rather than sold in the open market. After these transactions, he directly held 28,119 shares of common stock and 4,907 stock options.
Insulet Corp EVP and COO Benjamin Eric reported a mix of equity awards and share withholding transactions. He received a grant of 3,822 shares of common stock as an annual restricted stock unit award, which will vest in three equal installments on the first, second, and third anniversaries of the grant date. He was also granted 9,946 non-qualified stock options that become exercisable in four equal installments on each of the first four anniversaries of the grant date.
In a separate transaction, 395 shares of common stock were withheld at a price of $248.12 per share to cover tax obligations arising from RSU vesting, reducing his directly held common stock to 24,512 shares after the withholding.
Insulet Corp reported equity awards to senior executive Lisa Blair Davis, the SVP and Chief HR Officer. She received an annual grant of 5,570 employee stock options with an exercise schedule vesting in substantially equal installments over four years from the grant date of February 24, 2026.
On the same date, she was also granted 2,140 restricted stock units (RSUs), which vest in substantially equal installments over three years and settle into common shares on a one-for-one basis. After these grants, she directly owns 4,617 shares of common stock.
INSULET CORP executive Flavia Pease received new equity awards. On the reported date, the EVP & CFO was granted 3,822 shares of common stock and an employee stock option for 9,946 shares at an exercise price of $0.0000 per share.
The 3,822-share grant is an annual restricted stock unit award that vests in substantially equal installments on each of the first, second and third anniversaries of the grant date and settles one-for-one in common stock. The 9,946-share non-qualified stock option becomes exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date.
INSULET CORP President and CEO Ashley McEvoy received new equity awards. On February 24, 2026, McEvoy was granted an option to buy 26,143 shares of common stock at an exercise price of $0.00 per share and an award of 10,046 restricted stock units.
The option award becomes exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date. The restricted stock units vest in substantially equal installments on each of the first, second and third anniversaries and are settled one-for-one in common shares. Following these awards, McEvoy directly holds 23,962 common shares, with an additional 4 shares held indirectly through a trust.
INSULET CORP director-related trust buys additional shares. On February 25, 2026, a trust associated with director Michael R. Minogue purchased 2,030 shares of Insulet common stock in open-market transactions at a weighted average price of $246.23 per share. After this, the trust held 17,483 shares indirectly, while Minogue also held 778 shares directly.
Insulet Corp President and CEO Ashley McEvoy reported an open-market purchase of 4,300 shares of common stock on February 20, 2026 at a weighted average price of $239.35 per share. After this transaction, McEvoy directly owned 13,916 common shares, with an additional 4 shares held indirectly by a trust.
The filing notes that these 4,300 shares were bought in multiple trades at prices ranging from $238.55 to $241.56, with specified weighted average prices for each price band.
Insulet Corporation executive Prem Singh reported equity compensation activity in company stock. On February 12, 2026, Singh acquired 2,532 shares of common stock at $0 per share through the vesting of Performance Share Units, which were settled one-for-one in common shares.
On the same date, 861 shares were disposed of at $240.82 per share to cover tax obligations associated with the PSU vesting, leaving Singh with 5,158 shares of Insulet common stock held directly after these transactions.
Insulet Corp executive John W. Kapples reported equity award activity in company stock. On February 12, 2026, he acquired 5,246 shares of common stock at $0 upon satisfaction of performance criteria for Performance Share Units, which were settled one-for-one in shares. On the same date, 1,929 shares at $240.82 were disposed of as a tax-withholding transaction tied to the PSU vesting. After these transactions, Kapples directly owned 26,497 shares of Insulet common stock.
Insulet Corporation executive Laetitia Cousin reported equity award activity involving company common stock. On February 12, 2026, she acquired 1,808 shares at $0.00 per share from the vesting of performance share units that settled one-for-one in stock. On the same date, 564 shares were disposed of at $240.82 per share to cover associated tax obligations through share withholding. After these transactions, she directly owned 4,994 shares of Insulet common stock.
Insulet Corporation executive Lauren Budden reported equity compensation activity involving company common stock. On February 12, 2026, Budden acquired 1,808 shares of Insulet common stock at $0 per share through the settlement of performance share units that vested based on performance criteria.
Upon completion of these awards, 622 shares were withheld at a price of $240.82 per share to cover related tax obligations, a non‑market, tax-withholding disposition. After these transactions, Budden directly beneficially owned 8,188 shares of Insulet common stock.
Insulet Corporation’s EVP and COO, Benjamin Eric, reported equity compensation activity in company stock. On February 12, 2026, he acquired 7,236 shares of common stock at $0 per share, issued upon satisfaction of performance criteria for Performance Share Units settled one-for-one in stock. On the same date, 2,887 shares were disposed of in a tax-withholding transaction at $240.82 per share to cover obligations arising from the PSU vesting. After these transactions, he directly owned 21,085 shares of Insulet common stock.
A director of Insulet Corp (PODD) sold 1,851 shares of common stock on 12/15/2025. The transaction is coded "S," indicating a sale of non-derivative securities.
The reported sale price was $293.09 per share. After this transaction, the reporting person beneficially owns 2,158 shares of Insulet common stock, held in direct ownership form.
Insulet Corp (PODD) disclosed a director equity award on Form 4. On 10/31/2025, the reporting person received an initial grant tied to 477 shares, reported as an “A” (acquisition) at $0. Following the transaction, the filer beneficially owned 477 shares, held directly.
The award was granted as restricted stock units (RSUs) that fully vest on April 30, 2026, and are settled one-for-one in shares of common stock.
Insulet Corporation reporting insider transactions by EVP & CFO Flavia Pease shows two compensation awards dated 10/01/2025. The filing records a grant of 11,708 restricted stock units (RSUs) settled one-for-one into common shares; these RSUs vest in three equal annual installments beginning one year after the grant. The filing also shows an employee stock option award to buy 1,641 shares at a strike price of $305.98, exercisable in four substantially equal annual installments and expiring 10/01/2035. After the reported RSU grant the reporting person beneficially owned 15,337 shares. Transactions were reported via a Form 4 filed 10/02/2025.